Compare LARK & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LARK | CBUS |
|---|---|---|
| Founded | 1885 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.7M | 121.1M |
| IPO Year | 2001 | 2017 |
| Metric | LARK | CBUS |
|---|---|---|
| Price | $26.74 | $1.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 4.2K | ★ 799.0K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | 35.84 | ★ 74.33 |
| EPS | ★ 3.07 | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | $8.72 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.43 | $1.09 |
| 52 Week High | $31.00 | $4.19 |
| Indicator | LARK | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 37.44 |
| Support Level | $25.40 | $1.46 |
| Resistance Level | $27.06 | $1.59 |
| Average True Range (ATR) | 0.58 | 0.17 |
| MACD | 0.14 | 0.03 |
| Stochastic Oscillator | 73.23 | 31.88 |
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.